1275P Extended follow-up of DURVAST trial: A phase II study evaluating durvalumab treatment in HIV-1-infected patients with solid tumours by the Spanish lung cancer group

Authors :: R. Blanco
Judith Dalmau
Javier Martinez-Picado
M. González Cao
Teresa Moran
M. Provencio Pulla
J. De Castro Carpeno
Ana Drozdowskyj
R. Rosell Costa
R. Bernabé
Bonaventura Clotet
Julia G. Prado
O.J. Juan Vidal
Julià Blanco
Javier Garcia-Corbacho
M.A. Molina-Vila
B. Massuti Sureda
Andreas Meyerhans
Source :: Annals of Oncology. 31:S825
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Durvalumab
business.industry
Human immunodeficiency virus (HIV)
Phases of clinical research
Hematology
medicine.disease
medicine.disease_cause
Internal medicine
medicine
Lung cancer
business

Full Text Access

Tools